The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Differential natural killer cell–mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes
Open accessAbstract
Decline of peak viremia during acute HIV-1 infection occurs before the development of vigorous adaptive immunity, and the level of decline correlates inversely with the rate of AIDS progression, implicating a potential role for the innate immune response in determining disease outcome. The combined expression of an activating natural killer (NK) cell receptor, the killer immunoglobulin-like receptor (KIR) 3DS1, and its presumed ligand, human leukocyte antigen (HLA)–B Bw4-80I, has been associated in epidemiological studies with a slow progression to AIDS. We examined the functional ability of NK cells to differentially control HIV-1 replication in vitro based on their KIR and HLA types. NK cells expressing KIR3DS1 showed strong, significant dose- and cell contact–dependent inhibition of HIV-1 replication in target cells expressing HLA-B Bw4-80I compared with NK cells that did not express KIR3DS1. Furthermore, KIR3DS1+ NK cells and NKLs were preferentially activated, and lysed HIV-1 infected target cells in an HLA-B Bw4-80I–dependent manner. These data provide the first functional evidence that variation at the KIR locus influences the effectiveness of NK cell activity in the containment of viral replication.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Liu, R., Paxton, W. A., Choe, S., Ceradini, D., Martin, S. R., Horuk, R., MacDonald, M. E., Stuhlmann, H., Koup, R. A., & Landau, N. R. (1996) · Cell · doi:10.1016/s0092-8674(00)80110-5 · Cited by 3,074
The biology of human natural killer-cell subsets
Cooper, M. A., Fehniger, T. A., & Caligiuri, M. A. (2001) · Trends in Immunology · doi:10.1016/s1471-4906(01)02060-9 · Cited by 2,975
Control of Viremia in Simian Immunodeficiency Virus Infection by CD8 + Lymphocytes
Schmitz, J. E., Kuroda, M. J., Santra, S., Sasseville, V. G., Simon, M. A., Lifton, M. A., Racz, P., Tenner-Racz, K., Dalesandro, M., Scallon, B. J., et al. (1999) · Science · doi:10.1126/science.283.5403.857 · Cited by 2,187
CD107a as a functional marker for the identification of natural killer cell activity
Alter, G., Malenfant, J. M., & Altfeld, M. (2004) · Journal of Immunological Methods · doi:10.1016/j.jim.2004.08.008 · Cited by 1,410
Self-citationJin, X., Bauer, D. E., Tuttleton, S. E., Lewin, S., Gettie, A., Blanchard, J., Irwin, C. E., Safrit, J. T., Mittler, J., Weinberger, L., et al. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.6.991 · Cited by 1,407
Licensing of natural killer cells by host major histocompatibility complex class I molecules
Kim, S., Poursine-Laurent, J., Truscott, S. M., Lybarger, L., Song, Y.-J., Yang, L., French, A. R., Sunwoo, J. B., Lemieux, S., Hansen, T. H., et al. (2005) · Nature · doi:10.1038/nature03847 · Cited by 1,340
Severe Herpesvirus Infections in an Adolescent without Natural Killer Cells
Biron, C. A., Byron, K. S., & Sullivan, J. L. (1989) · New England Journal of Medicine · doi:10.1056/nejm198906293202605 · Cited by 1,269
Human NK Cell Education by Inhibitory Receptors for MHC Class I
Anfossi, N., André, P., Guia, S., Falk, C. S., Roetynck, S., Stewart, C. A., Breso, V., Frassati, C., Reviron, D., Middleton, D., et al. (2006) · Immunity · doi:10.1016/j.immuni.2006.06.013 · Cited by 1,211
Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS
Martin, M. P., Gao, X., Lee, J.-H., Nelson, G. W., Detels, R., Goedert, J. J., Buchbinder, S., Hoots, K., Vlahov, D., Trowsdale, J., et al. (2002) · Nature Genetics · doi:10.1038/ng934 · Cited by 1,189
Self-citationHLA and NK Cell Inhibitory Receptor Genes in Resolving Hepatitis C Virus Infection
Khakoo, S. I., Thio, C. L., Martin, M. P., Brooks, C. R., Gao, X., Astemborski, J., Cheng, J., Goedert, J. J., Vlahov, D., Hilgartner, M., et al. (2004) · Science · doi:10.1126/science.1097670 · Cited by 1,179
Self-citationKaslow, R. A., Carrington, M., Apple, R., Park, L., Muñoz, A., Saah, A. J., Goedert, J. J., Winkler, C., O'Brien, S. J., Rinaldo, C., et al. (1996) · Nature Medicine · doi:10.1038/nm0496-405 · Cited by 970
Self-citationContrasting Genetic Influence of CCR2 and CCR5 Variants on HIV-1 Infection and Disease Progression
Smith, M. W., Dean, M., Carrington, M., Winkler, C., Huttley, G. A., Lomb, D. A., Goedert, J. J., O'Brien, T. R., Jacobson, L. P., Kaslow, R., et al. (1997) · Science · doi:10.1126/science.277.5328.959 · Cited by 876
Self-citationInnate partnership of HLA-B and KIR3DL1 subtypes against HIV-1
Martin, M. P., Qi, Y., Gao, X., Yamada, E., Martin, J. N., Pereyra, F., Colombo, S., Brown, E. E., Shupert, W. L., Phair, J., et al. (2007) · Nature Genetics · doi:10.1038/ng2035 · Cited by 750
Self-citationThe Influence of HLA Genotype on AIDS
Carrington, M., & O'Brien, S. J. (2003) · Annual Review of Medicine · doi:10.1146/annurev.med.54.101601.152346 · Cited by 722
Self-citationEffect of a Single Amino Acid Change in MHC Class I Molecules on the Rate of Progression to AIDS
Gao, X., Nelson, G. W., Karacki, P., Martin, M. P., Phair, J., Kaslow, R., Goedert, J. J., Buchbinder, S., Hoots, K., Vlahov, D., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105313442203 · Cited by 487
Self-citationNatural killer cells as an initial defense against pathogens
Lodoen, M. B., & Lanier, L. L. (2006) · Current Opinion in Immunology · doi:10.1016/j.coi.2006.05.002 · Cited by 472
Genetic Acceleration of AIDS Progression by a Promoter Variant of CCR5
Martin, M. P. (1998) · Science · doi:10.1126/science.282.5395.1907 · Cited by 461
Self-citationDaniels, K. A., Devora, G., Lai, W. C., O'Donnell, C. L., Bennett, M., & Welsh, R. M. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.1.29 · Cited by 434
Recognition of peptide–MHC class I complexes by activating killer immunoglobulin-like receptors
Stewart, C. A., Laugier-Anfossi, F., Vély, F., Saulquin, X., Riedmuller, J., Tisserant, A., Gauthier, L., Romagné, F., Ferracci, G., Arosa, F. A., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503594102 · Cited by 406
What is a natural killer cell?
Moretta, A., Bottino, C., Mingari, M. C., Biassoni, R., & Moretta, L. (2002) · Nature Immunology · doi:10.1038/ni0102-6 · Cited by 349
Biassoni, R., Cantoni, C., Falco, M., Verdiani, S., Bottino, C., Vitale, M., Conte, R., Poggi, A., Moretta, A., & Moretta, L. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.2.645 · Cited by 342
Cella, M., Longo, A., Ferrara, G. B., Strominger, J. L., & Colonna, M. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.4.1235 · Cited by 340
Peptide Specificity in the Recognition of MHC Class I by Natural Killer Cell Clones
Malnati, M. S., Peruzzi, M., Parker, K. C., Biddison, W. E., Ciccone, E., Moretta, A., & Long, E. O. (1995) · Science · doi:10.1126/science.7863326 · Cited by 309
The Killer Immunoglobulin-Like Receptor Gene Cluster: Tuning the Genome for Defense
Bashirova, A. A., Martin, M. P., McVicar, D. W., & Carrington, M. (2006) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.7.080505.115726 · Cited by 265
Self-citationCarrington, M., Wang, S., Martin, M. P., Gao, X., Schiffman, M., Cheng, J., Herrero, R., Rodriguez, A. C., Kurman, R., Mortel, R., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20042158 · Cited by 231
Self-citationCutting Edge: Allele-Specific and Peptide-Dependent Interactions between KIR3DL1 and HLA-A and HLA-B
Thananchai, H., Gillespie, G., Martin, M. P., Bashirova, A., Yawata, N., Yawata, M., Easterbrook, P., McVicar, D. W., Maenaka, K., Parham, P., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.1.33 · Cited by 228
Self-citationKIR3DL1 Polymorphisms That Affect NK Cell Inhibition by HLA-Bw4 Ligand
Carr, W. H., Pando, M. J., & Parham, P. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.8.5222 · Cited by 224
Self-citationMavilio, D., Lombardo, G., Kinter, A., Fogli, M., La Sala, A., Ortolano, S., Farschi, A., Follmann, D., Gregg, R., Kovacs, C., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060894 · Cited by 191
Ward, J., Bonaparte, M., Sacks, J., Guterman, J., Fogli, M., Mavilio, D., & Barker, E. (2007) · Blood · doi:10.1182/blood-2006-06-028175 · Cited by 190
Vieillard, V., Strominger, J. L., & Debré, P. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504315102 · Cited by 183
Jennes, W., Verheyden, S., Demanet, C., Adjé-Touré, C. A., Vuylsteke, B., Nkengasong, J. N., & Kestens, L. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.10.6588 · Cited by 180
Gumperz, J. E., Barber, L. D., Valiante, N. M., Percival, L., Phillips, J. H., Lanier, L. L., & Parham, P. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.11.5237 · Cited by 179
Functional Polymorphism of the KIR3DL1/S1 Receptor on Human NK Cells
O’Connor, G. M., Guinan, K. J., Cunningham, R. T., Middleton, D., Parham, P., & Gardiner, C. M. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.1.235 · Cited by 162
Carrington, M. N., & Norman, P. J. (2003) · Cited by 159
Self-citationEvolution of Innate and Adaptive Effector Cell Functions during Acute HIV‐1 Infection
Alter, G., Teigen, N. C., Ahern, R., Streeck, H., Meier, A., Rosenberg, E. S., & Altfeld, M. A. (2007) · The Journal of Infectious Diseases · doi:10.1086/513878 · Cited by 151
Self-citationCarr, W. H., Rosen, D. B., Arase, H., Nixon, D. F., Michaëlsson, J., & Lanier, L. L. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.2.647 · Cited by 149
Self-citationMcVay (1996) · doi:10.1084/jem.184.4.1585 · Cited by 138
Peptide sequence requirements for the recognition of HLA-B*2705 by specific natural killer cells
Peruzzi, M., Parker, K. C., Long, E. O., & Malnati, M. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.8.3350 · Cited by 137
Chen, C., Busson, M., Rocha, V., Appert, M.-L., Lepage, V., Dulphy, N., Haas, P., Socié, G., Toubert, A., Charron, D. J., et al. (2006) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1705468 · Cited by 123
Interferon Induces Natural Killer Cell Blastogenesis In Vivo
Biron, C. A., Sonnenfeld, G., & Welsh, R. M. (1984) · Journal of Leukocyte Biology · doi:10.1002/jlb.35.1.31 · Cited by 118
Vitale, M., Sivori, S., Pende, D., Augugliaro, R., Donato, C. D., Amoroso, A., Malnati, M., Bottino, C., Moretta, L., & Moretta, A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.4.1453 · Cited by 114
Zambello, R., Falco, M., Chiesa, M. D., Trentin, L., Carollo, D., Castriconi, R., Cannas, G., Carlomagno, S., Cabrelle, A., Lamy, T., et al. (2003) · Blood · doi:10.1182/blood-2002-12-3898 · Cited by 111
Stewart‐Jones, G. B. E., di Gleria, K., Kollnberger, S., McMichael, A. J., Jones, E. Y., & Bowness, P. (2005) · European Journal of Immunology · doi:10.1002/eji.200425724 · Cited by 105
Yang, O. O., & Walker, B. D. (1997) · Advances in immunology · doi:10.1016/s0065-2776(08)60600-8 · Cited by 103
Bukowski, J. F., & Welsh, R. M. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.9.3481 · Cited by 72
Role of Natural Killer Cells in Virus Infections of Mice
Welsh, R. M., Biron, C. A., Bukowski, J. F., et al. (2008) · Survey and Synthesis of Pathology Research · doi:10.1159/000156943 · Cited by 23
Cited by
Functions of natural killer cells
Vivier, E., Tomasello, E., Baratin, M., Walzer, T., & Ugolini, S. (2008) · Nature Immunology · doi:10.1038/ni1582 · Cited by 3,943
Modulation of natural killer cell activity by viruses
Lisnić, V. J., Krmpotić, A., & Jonjić, S. (2010) · Current Opinion in Microbiology · doi:10.1016/j.mib.2010.05.011 · Cited by 1,003
Paust, S., Gill, H. S., Wang, B.-Z., Flynn, M. P., Moseman, E. A., Senman, B., Szczepanik, M., Telenti, A., Askenase, P. W., Compans, R. W., et al. (2010) · Nature Immunology · doi:10.1038/ni.1953 · Cited by 694
Cohen, M. S., Shaw, G. M., McMichael, A. J., & Haynes, B. F. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1011874 · Cited by 660
Maternal activating KIRs protect against human reproductive failure mediated by fetal HLA-C2
Hiby, S. E., Apps, R., Sharkey, A. M., Farrell, L. E., Gardner, L., Mulder, A., Claas, F. H., Walker, J. J., Redman, C. C., Morgan, L., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci43998 · Cited by 510
Self-citation
Metadata
- Authors
- Alter, G., Martin, M. P., Teigen, N., Carr, W. H., Suscovich, T. J., Schneidewind, A., Streeck, H., Waring, M., Meier, A., Brander, C., Lifson, J. D., Allen, T. M., Carrington, M., & Altfeld, M.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2007-11-19
- Volume
- 204
- Issue
- 12
- Pages
- 3027-3036
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2128306333
- Cited by
- 455
- References
- 46
- FWCI
- 11.96
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.